FROM Josh Sommer
Cancer and the Business of Medicine The annual meeting of the American Society of Clinical Oncology brings together the latest on cancer research and treatment. Patients and their families pray for news of a breakthrough. Businesses look for investments; entrepreneurs look for opportunities. Last week in Chicago, some 4000 studies were presented to 30,000 top experts — but one warned there's "a growing sense that our optimism needs to be tempered a bit." We hear from him and others about how financial conflicts, personal habits and occupational hazards impact inroads against the disease.
Cancer: Big Business and the Painstaking Search for a Cure Five years ago, cancer researchers were predicting "miracle treatments" — even vaccines -- based on the billions being spent on genetics. But the more they know, the more complicated cancer becomes, and even the American Cancer Society has tempered its optimism. Cancer victims, and members of Congress, are increasingly impatient with the slow pace of improvement. Are financial conflicts part of the problem? Given what’s known about personal habits like smoking, about occupational hazards and the environment, should more be spent on prevention?
'Do-or-die' time on healthcare bill President Trump has demanded a House vote today on replacing Obamacare…whatever the details might be. Despite his campaign promise that nobody would lose health insurance, that's possible for 24 million people if he were finally to sign this bill into law.
East Asia: President Trump's first foreign policy test Starting with North Korea's latest test of nuclear missiles, a chain of events is causing instability in Asia. Could it turn into the first real foreign policy crisis of the Trump Administration?